Condition
PSP - Progressive Supranuclear Palsy
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Not Yet Recruiting2
Unknown1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07264283Phase 2Not Yet RecruitingPrimary
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
NCT07217665Phase 2Not Yet RecruitingPrimary
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1
NCT06647641Recruiting
The CurePSP Genetics Program
NCT03330353UnknownPrimary
Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy
Showing all 4 trials